Landmarks Berhad:企業の戦略・SWOT・財務情報

◆英語タイトル:Landmarks Berhad - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C11942
◆発行会社(調査会社):MarketLine
◆発行日:2018年11月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:マレーシア
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Landmarks Berhad – Strategy, SWOT and Corporate Finance Report
Summary

Landmarks Berhad – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Landmarks Berhad (Landmarks) is an investment holding company. The company, through its subsidiaries, is involved in the hospitality and property investment businesses. Landmarks operates hotels and resorts, and is also focused on property development, wellness and spa, and township development business. It operates hotels under the brands of The Andaman and V Integrated Wellness (VIW) and Treasure Bay. Landmarks’ hotels are equipped with the lobby lounge, business centers, golf course, fitness centers, fun park, holistic and live entertainment facilities. It also offers construction, project financing, and consultancy services. The company operates through its subsidiaries across Malaysia, Australia, Indonesia, Singapore and Republic of Seychelles. Landmarks is headquartered in Kuala Lumpur, Malaysia.

Scope

- Detailed information on Landmarks Berhad required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Landmarks Berhad in the form of a SWOT analysis
- An in-depth view of the business model of Landmarks Berhad including a breakdown and examination of key business segments
- Intelligence on Landmarks Berhad’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Landmarks Berhad, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Landmarks Berhad and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Landmarks Berhad as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Landmarks Berhad’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Landmarks Berhad: Company Overview 9
Landmarks Berhad: Overview and Key Facts 9
Landmarks Berhad: Overview 9
Landmarks Berhad: Key Facts 9
Landmarks Berhad: Key Employees 11
Landmarks Berhad: Key Employee Biographies 12
Landmarks Berhad: Major Products and Services 13
Landmarks Berhad: Company History 14
Landmarks Berhad: Management Statement 15
Landmarks Berhad: Locations and Subsidiaries 17
Landmarks Berhad: Key Competitors 18
Landmarks Berhad: Company Analysis 19
Landmarks Berhad: Business Description 19
Landmarks Berhad: SWOT Analysis 20
Landmarks Berhad: SWOT Overview 20
Landmarks Berhad: Strengths 20
Landmarks Berhad: Weaknesses 21
Landmarks Berhad: Opportunities 21
Landmarks Berhad: Threats 21
Landmarks Berhad: Corporate Financial Deals Activity 23
Landmarks Berhad: Financial Deals Overview 23
Landmarks Berhad: Top Deals 2014 – 2018YTD* 24
Landmarks Berhad: Capital Raising 25
Landmarks Berhad: Recent Developments 26
Landmarks Berhad: News and Events Summary 26
Landmarks Berhad: Corporate Governance 26
Landmarks Berhad: Financial Performance 27
Appendix 28
Contact Us 28
Methodology 28
About MarketLine 29

List of Tables
Table 1: Landmarks Berhad: Key Facts
Table 2: Landmarks Berhad: Key Employees
Table 3: Landmarks Berhad: Company History
Table 4: Landmarks Berhad: Locations and Subsidiaries
Table 5: Landmarks Berhad: Key Competitors
Table 6: Landmarks Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: Landmarks Berhad: Top Deals 2014 - 2018YTD*
Table 8: Landmarks Berhad: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 9: Landmarks Berhad: Capital Raising by Deal Type (2014 - YTD*2018)
Table 10: Landmarks Berhad: News and Events Summary
Table 11: Landmarks Berhad: Corporate Governance
Table 12: Landmarks Berhad: Financial Performance

List of Figures
Figure 1: Landmarks Berhad: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Landmarks Berhad: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 3: Landmarks Berhad: Capital Raising by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Landmarks Berhad:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • SpringWorks Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary SpringWorks Therapeutics LLC (SpringWorks Therapeutics) is a drug development company that develops therapeutic medicines for various diseases. The company’s pipeline products include Nirogacestat, MEK ½ Inhibitor, Senicapoc and FAAH Inhibitor. Its Nirogacestat is a gamma secretase inhibitor …
  • MSD Pharmaceuticals Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary MSD Pharmaceuticals Pvt Ltd (MSD India), a subsidiary of Merck & Co Inc, is a healthcare products provider that offers prescription medicines, vaccines, biologic therapies, and animal health products. The company offers pipeline products such as medicines, tablets, capsules, solutions, and p …
  • MedicPen AB (MPEN):医療機器:M&Aディール及び事業提携情報
    Summary MedicPen AB (MedicPen) is a drug development company that manufactures, develops, and markets patented products. The company’s products include Medimi Pro and Medimi Smart. It also provides Medimi – MedicPen’s system for medication assistance. MedicPen offers automatic filling units for home …
  • PolyPid Ltd:製品パイプライン分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • International Vaccine Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary International Vaccine Institute (IVI) is a non-profit organization that discovers, develops and delivers vaccines. The organization's vaccines include bivalent inactivated oral cholera vaccine, Vi-DT typhoid conjugate vaccine, bivalent typhoid conjugate vaccine, shigella vaccine, norovirus v …
  • Target Corp:企業の戦略・SWOT・財務情報
    Target Corp - Strategy, SWOT and Corporate Finance Report Summary Target Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Grid2020, Inc.:電力:M&Aディール及び事業提携情報
    Summary Grid2020, Inc. (Grid2020) is a provider of smart grid solutions. The company offers an integrated distribution transformer monitoring solutions under the brand Optanode. The Optanode product family consists of sensors and smart analytics software and provides information about the distributi …
  • Church & Dwight Co Inc:企業のM&A・事業提携・投資動向
    Church & Dwight Co Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Church & Dwight Co Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • China Health Group Inc (8225):企業の財務・戦略的SWOT分析
    China Health Group Inc (8225) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Telefonica, S.A.:戦略・SWOT・企業財務分析
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cellmid Ltd (CDY):企業の財務・戦略的SWOT分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • The Avascent Group:企業の戦略・SWOT・財務情報
    The Avascent Group - Strategy, SWOT and Corporate Finance Report Summary The Avascent Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pioneer Natural Resources Co (PXD):石油・ガス:M&Aディール及び事業提携情報
    Summary Pioneer Natural Resources Co (Pioneer) is an independent oil and natural gas exploration and production company. Its principally operates in Eagle Ford Shale, Permian Basin, Raton Basin, and West Panhandle. In Permian Basin, the company carries out its exploration and production activities i …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure disease. The company develops pipeline products such as Atu027 and Atu111. Its Atu027 is developed for the treatment of pancreatic, head and neck cancer …
  • Venture Corporation Limited:企業の戦略・SWOT・財務情報
    Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Venture Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nisshin Seifun Group Inc:企業の戦略・SWOT・財務分析
    Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report Summary Nisshin Seifun Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Guangzhou Wondfo Biotech Co Ltd (300482):医療機器:M&Aディール及び事業提携情報
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that develops, manufactures and supplies rapid diagnostic reagents and related equipment. Its products include rapid quantitative test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo also of …
  • Verisante Technology Inc (VRS):製品パイプライン分析
    Summary Verisante Technology Inc (Verisante), develops and commercializes products for the early detection of all forms of skin cancer. The company’s key product offerings include Verisante Aura, Verisante Core and Verisante MSI Camera. The Verisante Aura is used for skin cancer detection, and Veris …
  • Murree Brewery Co. Ltd.
    Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Murree Brewery Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cogentix Medical Inc (CGNT):企業の財務・戦略的SWOT分析
    Summary Cogentix Medical Inc (Cogentix Medical), formerly Vision-Sciences Inc, is a medical device company that designs, develops, manufactures and markets fiberoptic and video endoscopy products. The company’s major products include PrimeSight endoscopy systems, Urgent PC neuromodulation system and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆